NEWS
Some Women May Not Need More Extensive Lymph Node Surgery for Breast Cancer
Clinical trials have shown that surgeons can remove less tissue from women who have early-stage, lymph node-negative breast cancer without harming their chances of the disease returning or their overall survival. Now, a study led by Dr. Armando Giuliano of the John Wayne Cancer Institute in Santa Monica, CA, adds to that knowledge by demonstrating that a surgical practice called axillary lymph node dissection isn’t necessary for some women with early-stage disease when cancer cells are found in the adjacent lymph nodes. Read more > >
Dutasteride May Slow the Growth of Early-Stage Prostate Cancer
Drug could help control the disease during active surveillanceBisphosphonate Use May Reduce Colorectal Cancer Risk
Results still need to be tested in a controlled clinical trialCommon Genetic Deletion Found in Brain Cancers
Patients with glioblastoma who had the deletion tended to have poor outcomesMore DNA Rearrangements Found in Prostate Cancers
Tumor sequences from seven patients suggest possible treatment avenuesCertain Physicians Are More Likely to Refer Patients to Clinical Trials
Survey identified points of intervention that could increase referrals
IN DEPTH
Targeted Therapies May Be Effective Against Rare Pancreatic Cancer
Drugs could represent first advance in 2 decades for this cancer type
Profiles in Cancer Research: Dr. Robin Yabroff
The NCI epidemiologist studies how cancer survivors interact with the health care system
Featured Clinical Trial: Treating Multiply Relapsed or Refractory Hairy Cell Leukemia
Will combining rituximab with pentostatin or bendamustine improve response rates?
UPDATES
HHS Update
- President’s FY 2012 Budget Proposal Calls for Small Increase for NCI
FDA Update
- FDA Approves First 3-D Device for Mammography
Cancer.gov Update
- TCGA Launches New Web Site
Notes
- Radiation and Cancer Symposium to Honor DCEG’s Elaine Ron
- SBIR Phase II Bridge Award Funding Available
- President’s Cancer Panel Addresses Accelerating Scientific Innovation
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
